Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lipigon Pharmaceuticals AB | 2,491,600 | net | 21 May 2025 | tx 5+2,491,600 |
| Kubator Therapeutics AB | 2,353,400 | net | 21 May 2025 | tx 6+2,353,400 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2025 | PURCHASE | Kubator Therapeutics AB | 1,652,000 | 0.09 SEK | first after silence |
| 30 May 2024 | OTHER | Kubator Therapeutics AB | 171,600 | 0.30 SEK | |
| 30 May 2024 | OTHER | Kubator Therapeutics AB | 171,600 | 0.20 SEK | deriv |
| 14 Dec 2023 | OTHER | Lipigon Pharmaceuticals AB | 343,200 | 0.30 SEK | |
| 14 Dec 2023 | OTHER | Lipigon Pharmaceuticals AB | 343,200 | 0.30 SEK | deriv |
| 06 Apr 2023 | PURCHASE | Lipigon Pharmaceuticals AB | 57,200 | 3.50 SEK | |
| 16 Jun 2022 | PURCHASE | Lipigon Pharmaceuticals AB | 96,000 | 2.15 SEK | |
| 22 Jun 2021 | PURCHASE | Kubator Therapeutics AB | 15,000 | 7.30 SEK |
1 purchase reported after at least 12 months of silence — most recent on 21 May 2025.